Class 2 recall-Sodiofolin 50 mg/ml solution for injection/infusion

Recalls and Alerts

Class 2 Recall

Class 2 recall-Sodiofolin 50 mg/ml solution for injection/infusion

medac GmbH (t/a medac Pharma LLP) is recalling the products and respective batches in this notification due to particles detected during long-term stability tests.

MHRA drug alert date: 20th July 2023

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-medac-gmbh-t-slash-a-medac-pharma-llp-sodiofolin-50-mg-slash-ml-solution-for-injection-slash-infusion-400mg-slash-8ml-vial-el-23-a-slash-26?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=f7cf9bf8-abed-479c-8071-de26a4cdf913&utm_content=immediately

Pip code	Product description	Supplier	Batch Numbers
ALLIANCE HEALTHCARE DO NOT STOCK	Sodiofolin 50 mg/ml solution for injection/infusion	medac Pharma LLP	G220393B G220393C

Further Information

For all medical enquiries, please contact medical information at medac Pharma LLP by email to info@medacpharma.co.uk or by telephone 01786 458086.

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.